Mark is a medically-qualified and seasoned drug developer with over 20 years’ pharmaceutical R&D experience.
He has worked at all phases of clinical drug development across a wide variety of therapeutic areas, including orphan diseases.
He was a Global Clinical R&D Director and then Director of Science and Medical Public Affairs at Pfizer in Sandwich. Earlier in his career he was an NHS anaesthetist and intensive care doctor.
